Argenx SE annual current ratio
2019
2020
2021
2022
2023
2024
2025
Argenx SE Current Ratio Growth & History (ARGX)
Argenx SE's current ratio was 5.23 for fiscal 2025.
View full Argenx SE company overviewArgenx SE annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 5.23 | −2.06 | −28.31% |
| 2024 | 2024-12-31 | 7.29 | −2.46 | −25.23% |
| 2023 | 2023-12-31 | 9.75 | 0.57 | +6.22% |
| 2022 | 2022-12-31 | 9.18 | 0.74 | +8.72% |
| 2021 | 2021-12-31 | 8.44 | 2.18 | +34.81% |
| 2020 | 2020-12-31 | 6.26 | −2.32 | −27.06% |
| 2019 | 2019-12-31 | 8.58 | — | — |
Argenx SE quarterly current ratio
Q4.19
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 5.12 | −0.47 | −8.45% |
| Q4 2025 | 2025-12-31 | 5.23 | −2.06 | −28.31% |
| Q2 2025 | 2025-06-30 | 5.60 | −2.94 | −34.43% |
| Q4 2024 | 2024-12-31 | 7.29 | −2.46 | −25.23% |
| Q2 2024 | 2024-06-30 | 8.53 | 0.06 | +0.76% |
| Q4 2023 | 2023-12-31 | 9.75 | 0.57 | +6.22% |
| Q2 2023 | 2023-06-30 | 8.47 | −2.60 | −23.50% |
| Q4 2022 | 2022-12-31 | 9.18 | 0.74 | +8.72% |
| Q2 2022 | 2022-06-30 | 11.07 | −0.67 | −5.69% |
| Q4 2021 | 2021-12-31 | 8.44 | 2.18 | +34.81% |
| Q2 2021 | 2021-06-30 | 11.74 | — | — |
| Q4 2020 | 2020-12-31 | 6.26 | −2.32 | −27.06% |
| Q4 2019 | 2019-12-31 | 8.58 | — | — |
Argenx SE current ratio trends
Over the last five fiscal years, Argenx SE's current ratio decreased from 6.26 to 5.23, a change of −1.04. The latest reported quarter, Q2 2026, shows 5.12.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Argenx SE source filings ↗Community posts
Argenx sales expand as additional clinical and regulatory work advances
Argenx ($ARGX) reported third-quarter 2026 product sales of approximately $1.7 billion, an increase of 54% from a year earlier and 13% from the preceding quarter. Net profit attributable to shareholders increased to $506 million from $344 m ...
